Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Clinical Experts Detail How They Use Varian's TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments

September 14, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

BARCELONA, Spain, Sept. 14 /- Cancer treatment experts today reported their experiences with early treatments using the new TrueBeam system from Varian Medical Systems (NYSE: VAR ), aimed at increasing the speed and precision of radiotherapy and radiosurgery treatments. Clinicians from...

TOPICS:

ASU receives 2-year, $5.3 million DARPA award to safeguard soldiers from infectious diseases

September 14, 2010 7:35 am | by EurekAlert | News | Comments

(Arizona State University) Scientists at the Biodesign Institute at Arizona State University have received a 2-year, $5.3 million grant from the Defense Advanced Research Projects Agency to protect warfighters in the event of exposure to infectious diseases during deployment. Dr. Stephen...

TOPICS:

Corgenix to Host Conference Call to Discuss Fiscal 2010 Results

September 14, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

DENVER, Sept. 14 /- Corgenix Medical Corporation (OTC Bulletin Board: CONX ), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, September 23, 2010, at 4:00 PM EDT to discuss the Company's financial and operating performance for its fiscal...

TOPICS:
Advertisement

Federal Register: Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting

September 14, 2010 7:31 am | by U.S. Food & Drug Administration | News | Comments

On October 8, 2010, the committee will discuss and make recommendations regarding clinical trial design issues for devices indicated for the treatment of depression.

TOPICS:

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

September 14, 2010 5:32 am | by Boston Scientific | News | Comments

Company to present clinical data on its platinum chromium PROMUS® Element™ and TAXUS® Element™ Coronary Stent Systems

TOPICS:

Alere looking for $350M from notes placement

September 14, 2010 4:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Alere Inc., the Waltham life sciences firm formerly known as Inverness Medical Innovations Inc., plans to raise $350 million through a private placement of senior subordinated notes, with proceeds being used for working capital and general purposes.

Isis Pharmaceuticals to Present at the UBS Global Life Sciences Conference

September 14, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Sept. 14 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at UBS' Global Life Sciences Conference on Tuesday, September 21, 2010 at 4:00 p.m. ET at the Grand Hyatt New...

TOPICS:

Quinton Oswald Named Chief Executive Officer of SARcode Corporation

September 14, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

BRISBANE, Calif., Sept. 14 /- SARcode Corporation, a privately-held biotechnology company focused on developing a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists, today announced that Quinton Oswald has joined the company as Chief Executive Officer. Mr. Oswald...

TOPICS:
Advertisement

TeleHealth Services and Reading Hospital and Medical Center Partner to Reach Technology-Driven Patient Education Goals

September 14, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

READING, Pa. and RALEIGH, N.C., Sept. 14 /- TeleHealth Services, the nation's leading provider of healthcare grade televisions and interactive patient education solutions, today announced a new partnership with The Reading Hospital and Medical Center (TRHMC). The 671-bed hospital chose...

TOPICS:

Stereotaxis to Present at the CL King Best Ideas Conference and the Stifel Nicolaus Healthcare Conference

September 14, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Sept. 14 /- Stereotaxis, Inc. (Nasdaq: STXS ) today announced that executive management will present at the following investor conferences: The CL King 8th Annual Best Ideas Conference to be held September 15-16, 2010 at the Omni Berkshire Place Hotel in New York City....

TOPICS:

ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firm's Growing Client Base in Germany

September 14, 2010 12:33 am | by Bio-Medicine.Org | News | Comments

FRANKFURT, Germany, Sept. 14 /- Dr. Rolf Badenhoop M.D., a 20-year veteran of the consulting and pharmaceutical industries in Europe, recently joined global sales and marketing consulting firm ZS Associates as associate principal. Badenhoop is based in the company's Frankfurt office. "I...

TOPICS:

SunEdison signs MOU for 400MW of solar projects with provincial government in Korea

September 13, 2010 10:34 pm | by I-Micronews | News | Comments

SunEdison, the solar energy development subsidiary of MEMC Electronic Materials (WFR ), and Gyeongsangnam-do ("GSND"), a provincial government in southeastern Korea, today announced the execution of a non-binding Memorandum of Understanding (MOU) for the establishment of 400 megawatts...

New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patients

September 13, 2010 10:31 pm | by EurekAlert | News | Comments

(Burness Communications) A widely prescribed class of drugs is highly effective in reducing common bone fractures in people with osteoporosis, but an expert panel announces that these same drugs -- when used long term -- may be related to unusual but serious fractures of the thigh bone.

TOPICS:

Study identifies underlying dysfunction of seemingly non-critical heart condition

September 13, 2010 10:31 pm | by EurekAlert | News | Comments

(Nationwide Children's Hospital) Repairing small, seemingly benign holes in a child's heart may be more clinically important than previously thought, as dysfunction could be lurking out of sight. These are the findings from a study conducted by doctors and researchers at Nationwide...

TOPICS:

Welsh scientists 'clone' human virus

September 13, 2010 4:37 pm | by EurekAlert | News | Comments

(Cardiff University) A team of Welsh scientists have successfully cloned a human virus offering new hope for the treatment of potentially life-threatening diseases. Human cytomegalovirus is a major infectious cause of congenital malformations worldwide. The virus is also known to...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading